High‐methylation subgroup significantly correlates with more advanced tumors with greater tumor thickness and worse prognosis, and silencing of one of the most frequently methylated genes, TFPI2, is found to increase cell proliferation and invasion. This evidence concerns the gene TFPI2 and neoplasm.